N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.
about
P1343
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerCurrent status and perspectives of patient-derived xenograft models in cancer research.Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide.Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assayAurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation.Therapeutic Approaches Targeting MYC-Driven Prostate CancerSrc promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy.FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.Defining and Targeting the Oncogenic Drivers of Neuroendocrine Prostate Cancer.Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective.Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.Emerging Variants of Castration-Resistant Prostate Cancer.Family matters: How MYC family oncogenes impact small cell lung cancer.Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression.Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.Molecular determinants of prostate cancer metastasis.MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance.Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells.Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).The Genomics of Prostate Cancer: emerging understanding with technologic advances.Biology and evolution of poorly differentiated neuroendocrine tumors.SIRT1 contributes to neuroendocrine differentiation of prostate cancer.Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies.Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer.Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Integrative (epi) Genomic Analysis to Predict Response to Androgen-Deprivation Therapy in Prostate Cancer.Epigenetic Regulation in Prostate Cancer Progression.Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.The multifaceted allosteric regulation of Aurora kinase A.
P2860
Q28771715-DF718D8F-BDFE-43DC-9CFC-1848A2BAE723Q33667686-DEFA680F-0D74-4BE1-BA8F-DB52C522C8EEQ36083012-C5743E7F-BF8A-486D-81E6-A18E8D668978Q36155367-8A860AE9-D41B-44B3-B6F4-D513BB7317A6Q36398998-17BD4798-0F3C-4614-8626-AABC43595A97Q36831507-26D5586B-9D18-4E8D-8F9C-6B6484A45AA4Q37399824-EC5C2658-3C9E-48D7-BBF8-85B1D62CE068Q37676253-900C9010-7EEB-4CA8-8A93-4BFFC6661601Q37705831-E7C909A8-6C1E-4C2B-A47A-034A98354EE3Q37709535-3B81BE73-5DF2-488C-8135-821CD2FC5934Q38607675-D921E3DF-050A-41C5-AEAF-27B578B59EFAQ38722718-E5E0551A-E5C6-47F9-AFFD-D6D440ED4C6AQ38737415-0C01A9C4-BBA0-4383-93F8-DB607336A10FQ38778879-4F24A43D-7CB6-4B44-8F9C-613302A47B98Q38836163-5B80F18B-A35F-44E5-B76A-D6435568BA62Q38930155-AE4B390E-6A5F-41BF-887E-4CF2B9A31C8AQ39016544-ECCCDA51-412B-40E4-A469-B964FC0DDB04Q39210257-C60C2186-A8F4-4B9A-BE1B-88FC51819571Q39454070-36B371A6-6A11-4FFE-A6A5-9CACC4F93291Q39515247-BFBBBD78-6692-4CFA-B840-B5C5EEC69C1FQ42198722-78C76610-C64E-449F-8AC5-9CBF4E2E9C51Q43578455-50B027AC-43F0-4E3A-97FE-F8DE0503AC3CQ45742884-F896DDDC-857E-4F08-9589-5DF24055725DQ47103669-AE58B10E-035A-4A75-BC27-E0B74CF848F0Q47111931-EF390CEC-E16C-46E3-B38F-27E07D302EA3Q47120728-52E47FAF-7ABE-4C79-B943-9713261B2FDAQ47595568-3C245B82-4E6E-4CFE-BAD7-7EB0F48D4936Q48125169-253F6447-25B7-4FF1-ABA7-C0C8C50B3257Q48310246-A6089B9C-CE78-403E-B93A-71ADE08CDEC3Q48317607-3B2691AF-4192-4AEF-9DB6-4D66002FCF5DQ48320507-F1BB53A5-FB65-4145-A3E2-349FC7B43003Q49522217-DC2E3457-369F-4CFC-8649-B7AE04A68E54Q49540308-16705DD0-7074-403A-BB72-013FF15F3E6FQ50420907-0DD1A499-6873-4892-85DC-EADC3851CB37Q52568663-DFDBC4A6-C67F-4155-A641-88D642AF92E3Q53682879-9868B87F-BE49-4AD6-B7A9-74C5D87ADFBFQ53692348-ABD68C6E-6BF5-4FCF-A28D-EBE68E44E6D7Q54974720-2F4CC2D6-3843-42D0-8AC3-42AA697838ECQ55265680-2EA7549F-0B9F-4ADC-8DBE-C1D19A29583AQ55486788-BA6A7977-8E3C-4C06-B3FE-A7AF7885E8A3
P2860
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@ast
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@en
type
label
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@ast
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@en
prefLabel
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@ast
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@en
P2093
P2860
P1433
P1476
N-Myc Drives Neuroendocrine Pr ...... man Prostate Epithelial Cells.
@en
P2093
Artem Sokolov
Bryan A Smith
Colleen Mathis
Donghui Cheng
Erin F McCaffrey
Jiaoti Huang
John W Phillips
Joshua M Stuart
Jung Wook Park
Justin G Meyerowitz
P2860
P304
P356
10.1016/J.CCELL.2016.03.001
P577
2016-03-24T00:00:00Z